Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?

Montironi R, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Santoni M, Briganti A, Montorsi F, Cheng L.

Diagn Pathol. 2014 Oct 18;9:190. doi: 10.1186/s13000-014-0190-z.

3.
4.

Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.

Tarján M, Chen HH, Tot T, Wu W, Lenngren A, Dean PB, Tabár L.

Scand J Urol Nephrol. 2012 Aug;46(4):258-66. doi: 10.3109/00365599.2012.675586.

PMID:
22519924
5.

Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.

Kryvenko ON, Gupta NS, Virani N, Schultz D, Gomez J, Amin A, Lane Z, Epstein JI.

Arch Pathol Lab Med. 2013 May;137(5):610-7. doi: 10.5858/arpa.2012-0128-OA.

PMID:
23627451
6.

Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.

Ellis CL, Partin AW, Han M, Epstein JI.

J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056.

PMID:
23727307
8.

A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.

Miyamoto H, Hernandez DJ, Epstein JI.

Hum Pathol. 2009 Dec;40(12):1693-8. doi: 10.1016/j.humpath.2009.05.001.

PMID:
19683331
9.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x.

10.

Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.

Kothari PS, Scardino PT, Ohori M, Kattan MW, Wheeler TM.

Am J Surg Pathol. 2001 Nov;25(11):1429-32.

PMID:
11684961
11.
12.

Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.

Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Gleason DF.

Cancer. 2002 Jun 15;94(12):3141-9.

13.

Pathological extension of prostate cancer as defined by Gleason score on biopsy.

Dall'Oglio MF, Crippa A, Paranhos M, Nesrallah LJ, Leite KR, Srougi M.

Int Braz J Urol. 2005 Jul-Aug;31(4):326-30.

14.

Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.

Hoedemaeker RF, Rietbergen JB, Kranse R, Schröder FH, van der Kwast TH.

J Urol. 2000 Aug;164(2):411-5.

PMID:
10893598
15.

Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.

Turker P, Bas E, Bozkurt S, Günlüsoy B, Sezgin A, Postacı H, Turkeri L.

Urol Oncol. 2013 Jan;31(1):93-8. doi: 10.1016/j.urolonc.2010.10.009.

PMID:
21316989
16.

Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.

Packiam VT, Patel SG, Pariser JJ, Richards KA, Weiner AB, Paner GP, VanderWeele DJ, Zagaja GP, Eggener SE.

Urology. 2015 Oct;86(4):777-82. doi: 10.1016/j.urology.2015.07.009.

PMID:
26196240
17.
18.

Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.

Gottipati S, Warncke J, Vollmer R, Humphrey PA.

Am J Surg Pathol. 2012 Jun;36(6):900-7. doi: 10.1097/PAS.0b013e3182495dee.

PMID:
22367295
19.
20.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
Items per page

Supplemental Content

Support Center